SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 59 filers reported holding SIO GENE THERAPIES INC in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $222,000 | – | 81,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cladis Investment Advisory, LLC | 1,104,000 | $1,424,000 | 1.31% |
| Prosight Management, LP | 802,180 | $1,035,000 | 0.62% |
| Privium Fund Management B.V. | 1,806,542 | $2,367,000 | 0.47% |
| Rubric Capital Management LP | 3,000,000 | $3,870,000 | 0.18% |
| ACT CAPITAL MANAGEMENT, LLC | 185,000 | $239,000 | 0.17% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $7,629,000 | 0.15% |
| APOGEM CAPITAL LLC | 60,245 | $78,000 | 0.05% |
| Clearline Capital LP | 218,506 | $282,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 166,806 | $215,000 | 0.03% |
| Hudson Bay Capital Management LP | 1,800,000 | $2,322,000 | 0.02% |